Jasper Therapeutics (JSPR) Financials: Revenue & Earnings

JSPR price $0.54 +0.02 +3.84%

Ticker
JSPR
Price
$0.54
Change
+0.02 +3.84%
Market cap ?
$17.93M
P/E ?
-0.33
Forward P/E ?
2.67
Dividend yield ?
0.00%
Beta ?
3.17
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
67
Value
60
Quality
42
Growth
100

Stocklytics score rationale: value 60, quality 42, growth 100.

Financials

2019202020212022202320242025
0000000

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases. The company’s lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factor from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic…

Fair value

JSPR fair value Not meaningful. Price $0.54.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare JSPR

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.06—6.00M
2026-08-14-0.10-0.27——
2026-05-14-0.04-0.46——
2026-03-30-0.32-0.79——
2025-11-10-1.13-1.01——
2025-08-13-1.74-1.20——
2025-05-12-1.41-1.17——
2025-02-27-1.62-1.271.17M—
2024-11-07-1.24-1.09——
2024-08-13-0.97-1.09——
2024-05-14-1.03-1.26——
2024-03-04-1.50-1.652.05M—
2023-11-09-1.60-1.50——
2023-08-11-1.50-1.30——
2023-05-12-1.60-1.50——
2023-03-08-3.60-3.70——
2022-11-10-3.20-3.50——
2022-08-12-2.90-2.90——
2022-05-12-0.60-3.60——
2022-03-20-0.79-0.34——
2021-11-12-0.69-0.28——
2021-08-16-0.84———
2021-05-24-0.26———
2021-03-30-0.26———
2020-11-10-1.08———
2020-08-14-16.06———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-31WIGGANS THOMAS GBuy7.50K$0.634.72K
2026-07-31Lucas SvetlanaBuy7.50K$0.634.72K
2026-07-31Crutcher Patrick JBuy7.50K$0.634.72K
2026-07-31EMSTER KURT VONBuy7.50K$0.634.72K
2026-07-31Shizuru Judith AnneBuy7.50K$0.634.72K
2026-07-20Ros Matthew EBuy881——
2026-07-20Crutcher Patrick JBuy888——
2026-07-16Keenan GregOther103.20K$0.011.03K
2026-07-16Keenan GregOther92.28K$0.6156.29K
2026-07-16Song WenruOther0——
2026-07-16Song WenruOther0——
2026-07-16Song WenruOther630$2.721.71K
2026-07-16Song WenruOther1.97K$2.835.58K
2026-07-16Song WenruOther5.88K$3.5921.13K
2026-07-16Song WenruOther563$165.9293.41K
2026-07-16Song WenruOther1.76K$172.63304.52K
2026-07-16Song WenruOther5.26K$218.991.15M
2026-07-16Ros Matthew EOther103.20K$0.011.03K
2026-07-16Ros Matthew EOther92.28K$0.6156.29K
2026-07-16Crutcher Patrick JBuy15.00K$0.7711.61K
2026-07-16Crutcher Patrick JOther0——
2026-07-16Crutcher Patrick JOther463.45K——
2026-02-06Mahal Jeetinder SinghBuy500.00K$1.35675.00K
2026-01-02MARTELL RONBuy234.00K$1.84430.56K
2026-01-02Mahal Jeetinder SinghBuy90.00K$1.84165.60K
2026-01-02CROSS HERBBuy90.00K$1.84165.60K
2025-09-22WIGGANS THOMAS GBuy41.00K$2.4399.63K
2025-09-22WIGGANS THOMAS GBuy41.00K$2.92119.72K
2025-09-22Lucas SvetlanaBuy20.00K$2.4348.60K
2025-09-22Lucas SvetlanaBuy20.00K$2.9258.40K
2025-09-22MARTELL RONBuy41.00K$2.4399.63K
2025-09-22MARTELL RONBuy41.00K$2.92119.72K
2025-09-22Shizuru Judith AnneBuy41.00K$2.4399.63K
2025-09-22Shizuru Judith AnneBuy41.00K$2.92119.72K
2025-07-03Brun Scott C.Buy7.50K$6.7750.77K
2025-07-03EMSTER KURT VONBuy7.50K$6.7750.77K
2025-07-03Shizuru Judith AnneBuy7.50K$6.7750.77K
2025-07-03Nolet ChrisBuy7.50K$6.7750.77K
2025-07-03Kapoor VishalBuy7.50K$6.7750.77K
2025-07-03WIGGANS THOMAS GBuy7.50K$6.7750.77K
2025-07-03Lucas SvetlanaBuy7.50K$6.7750.77K
2025-06-04MARTELL RONBuy234.00K$6.001.40M
2025-06-04Mahal Jeetinder SinghBuy90.00K$6.00540.00K
2025-06-04CROSS HERBBuy90.00K$6.00540.00K
2025-06-04Tucker Edwin JonathanBuy90.00K$6.00540.00K
2025-02-13Mahal Jeetinder SinghBuy50.00K$6.20310.00K
2025-02-13MARTELL RONBuy130.00K$6.20806.00K
2025-02-13CROSS HERBBuy50.00K$6.20310.00K
2025-02-13Tucker Edwin JonathanBuy50.00K$6.20310.00K
2024-12-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-12-12Mahal Jeetinder SinghSell900$22.1119.90K
2024-12-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-09-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-09-12Mahal Jeetinder SinghSell900$21.2319.10K
2024-09-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-06-18Lucas SvetlanaBuy15.00K$23.19347.85K
2024-06-18Lucas SvetlanaOther0——
2024-06-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-06-12Mahal Jeetinder SinghSell900$24.1621.74K
2024-06-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-06-10MARTELL RONBuy20.00K——
2024-06-10MARTELL RONBuy10.00K$23.95239.50K
2024-06-07Tucker Edwin JonathanBuy400$4.171.67K
2024-06-06French Anna LouiseBuy7.50K$25.41190.57K
2024-06-06Nolet ChrisBuy7.50K$25.41190.57K
2024-06-06Shizuru Judith AnneBuy7.50K$25.41190.57K
2024-06-06Kapoor VishalBuy7.50K$25.41190.57K
2024-06-06WIGGANS THOMAS GBuy7.50K$25.41190.57K
2024-06-06Brun Scott C.Buy7.50K$25.41190.57K
2024-06-06EMSTER KURT VONBuy7.50K$25.41190.57K
2024-03-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-03-12Mahal Jeetinder SinghSell900$26.4423.79K
2024-03-12Mahal Jeetinder SinghBuy900$7.106.39K
2024-02-15MARTELL RONBuy100.00K$17.951.79M
2024-02-15Mahal Jeetinder SinghBuy40.00K$17.95718.00K
2024-02-15CROSS HERBBuy40.00K$17.95718.00K
2024-02-15Tucker Edwin JonathanBuy45.00K$17.95807.75K
2024-02-08Carlyle Group Inc.Buy190.00K$12.952.46M
2024-02-08Velan Capital Investment Management LPBuy350.00K$12.954.53M
2023-11-28WIGGANS THOMAS GBuy10.00K$0.656.49K
2023-11-21WIGGANS THOMAS GBuy10.00K$0.646.38K
2023-11-20WIGGANS THOMAS GBuy10.00K$0.636.31K
2023-11-17WIGGANS THOMAS GBuy10.00K$0.605.97K
2023-11-16WIGGANS THOMAS GBuy10.00K$0.605.96K
2023-11-01WIGGANS THOMAS GBuy110.00K$0.6975.90K
2023-11-01WIGGANS THOMAS GOther0——
2023-10-13Lis WilliamSell7.96K$0.856.78K
2023-10-12Mahal Jeetinder SinghSell37.13K$0.8531.56K
2023-10-12MARTELL RONSell87.53K$0.8574.40K
2023-09-22CROSS HERBBuy550.00K$0.78429.00K
2023-09-22CROSS HERBOther0——
2023-06-20Brun Scott C.Buy94.00K$1.35126.90K
2023-06-20Brun Scott C.Other0——
2023-06-13Mahal Jeetinder SinghBuy9.00K$0.716.39K
2023-06-13Mahal Jeetinder SinghSell9.00K$1.6614.91K
2023-06-13Mahal Jeetinder SinghBuy9.00K$0.716.39K
2023-06-12Tucker Edwin JonathanBuy400.00K$1.62648.00K
2023-06-12Tucker Edwin JonathanOther0——
2023-06-07Kapoor VishalBuy47.00K$1.6075.20K
2023-06-07Klein Lawrence OttoBuy47.00K$1.6075.20K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 47, holders -13 vs prior quarter. Ownership 41.82%.

HolderSharesChangeChange %Value
VELAN CAPITAL INVESTMENT MANAGEMENT LP2.67M00.00%1.12M
ACORN CAPITAL ADVISORS, LLC1.44M26.67K+1.89%604.03K
KINGDON CAPITAL MANAGEMENT, L.L.C.1.35M00.00%569.24K
VANGUARD CAPITAL MANAGEMENT LLC1.17M-576-0.05%493.42K
ROCK SPRINGS CAPITAL MANAGEMENT LP1.10M00.00%463.41K
CARLYLE GROUP INC.1.07M00.00%448.87K
GSA CAPITAL PARTNERS LLP534.70K515.61K+2701.81%225.00K
MILLENNIUM MANAGEMENT LLC486.93K-1.13M-69.90%205.00K
LION POINT CAPITAL, LP465.00K00.00%195.76K
GEODE CAPITAL MANAGEMENT, LLC263.81K-53.87K-16.96%111.09K
RENAISSANCE TECHNOLOGIES LLC237.90K60.40K+34.03%100.16K
CITADEL ADVISORS LLC206.00K178.00K+635.71%86.73K
BLACKROCK, INC.169.63K-72.43K-29.92%71.41K
VANGUARD FIDUCIARY TRUST CO149.94K00.00%63.13K
ADAR1 CAPITAL MANAGEMENT, LLC140.00K00.00%58.94K
QUARRY LP131.53K00.00%55.37K
JANE STREET GROUP, LLC101.74K80.33K+375.10%42.83K
JANE STREET GROUP, LLC83.60K62.19K+290.38%35.20K
UBS GROUP AG58.76K-22.36K-27.56%24.74K
JAIN GLOBAL LLC51.19K33.16K+184.01%21.55K
OSAIC HOLDINGS, INC.45.85K5.00K+12.24%19.30K
STATE STREET CORP44.70K00.00%18.82K
NORTHERN TRUST CORP41.88K7.31K+21.13%17.63K
DIKER MANAGEMENT LLC35.00K00.00%15.00K
QUBE RESEARCH & TECHNOLOGIES LTD33.72K33.72KNew14.20K

Earnings and financials

Jasper Therapeutics, Inc. (JSPR) trades at $0.54, with a market cap of $17.93M and a trailing P/E of -0.33. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
0000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Jasper Therapeutics (JSPR) Financials: Revenue & Earnings

JSPR$0.54+0.02 +3.84%

$17.93M

Market Cap

-0.33

P/E

2.67

Forward P/E

67

Score

Price History